Order Article Reprints

Dai Y, Zhang S, Yang L, Liu P, Zhang T, Li H, Pang Y, Ma S, Zhang Y, Zhao T. Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate. Antioxidants. 2026; 15(6):662. https://doi.org/10.3390/antiox15060662

Dai, Yangyan, Silu Zhang, Lijia Yang, Penglong Liu, Tingfeng Zhang, Hailong Li, Yuchen Pang, Shijing Ma, Yehui Zhang, and Tiantian Zhao. 2026. "Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate" Antioxidants 15, no. 6: 662. https://doi.org/10.3390/antiox15060662

Dai, Y., Zhang, S., Yang, L., Liu, P., Zhang, T., Li, H., Pang, Y., Ma, S., Zhang, Y., & Zhao, T. (2026). Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate. Antioxidants, 15(6), 662. https://doi.org/10.3390/antiox15060662